Why arent people buying this stock. Rothschild were prepared to...

Why arent people buying this stock. Rothschild were prepared to pay $5million into Medicalcorps 81% owned Objectivision (www.objectivision.com.au) which to my way of thinking values Objectivision at $20 million.This would be a wholesale entry price and at todays closing price the market values MOD at about $13 million.This market cap doesnt even take into account there Chinese operations nor thier investment in Symbion. It doent even take into account the FDA approval for Accumap.The distibution agreement with Hiedleberg Engineering and the the potential for the Accumap to be the gold standard for the detection of gloucoma and other eye diseases let alone the potential for the Accumap in the field of neurology. If you are looking for a cheap entry into this stock there is no better time than now. It will go